Weight Management Pills, PMOS Insights, and AI in Healthcare

In this episode, Dr. Chi-Ming Chow discusses Orforglipron, a new weight management pill, covering study funding, expert insights, mechanisms, and cost. He reviews study results on weight maintenance and rebound. The episode also explores GLP-1 receptor agonists and their link to breast cancer, including findings and criticisms. Dr. Chow examines the renaming of polycystic ovary syndrome (PMOS), its characteristics, impact, and treatment options. Additionally, he discusses AI in healthcare, its benefits, concerns, and regulatory challenges. The episode concludes with talks on patient lawsuits, accountability, and the need for AI guidelines.